Ellipsoid zone integrity may be an important biomarker in predicting the progression of geographic atrophy in eyes with dry age-related macular degeneration.
In addition, avacincaptad pegol (ACP) may slow geographic atrophy (GA) progression in eyes with more severe ellipsoid zone (EZ) damage at baseline.
“Utilizing biomarkers such as this can be really helpful to be able to guide treatment of who to select for treatment as well as to be able to assess if they’re having a response,” Katherine E. Talcott, MD, said at the American Society of Retina Specialists annual meeting.
In a